13 Hepatitis C and hepatocellular carcinoma

Biomedical Research Reports

Volumn 2, Issue C, 2000, Pages 265-275

  Di Bisceglie, Adrian M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957057690     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(00)80017-4     Document Type: Article

References (44)

1. Colombo M., Kuo G., Choo Q.L., et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2 (1989) 1006-1008
2. Bruix J., Barrera J.M., Calvet X., et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2 (1989) 1004-1006
3. Colombo M., Rumi M.G., Donato M.F., et al. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci 36 (1991) 1130-1131
4. Mangia A., Vallari D.S., and Di Bisceglie A.M. Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol 43 (1994) 125-128
5. Bukh J., Miller R.H., Kew M.C., and Purcell R.H. Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma. Proc Natl Acad Sci U S A 90 (1993) 1848-1851
6. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Hepatology 26 (1997) 34S-38S
7. Taylor-Robinson S.D., Foster G.R., Arora S., Hargreaves S., and Thomas H.C. Increase in primary liver cancer in the UK, 1979-94. Br Med J 350 (1997) 1142-1143
8. El-Serag H., and Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
9. Hasan F., Jeffers L.J., de Medina M., et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 12 (1990) 589-591
10. Di Bisceglie A.M., Klien J., Choo Q., et al. Role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 86 (1991) 335-338
11. Kiyosawa K., Sodeyama T., Tanaka E., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 (1990) 671-675
12. Di Bisceglie A.M., Simpson L.H., Lotze M.T., and Hoofnagle J.H. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 19 (1994) 222-226
13. Tong M.J., El-Farra N.S., Reikes A.R., and Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332 (1995) 1463-1466
14. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C: a restrospective follow-up study of 384 patients. Gastroenterology 112 (1997) 463-472
15. National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C. Hepatology 26 (1997) 2S-10S
16. Mandelli C., Fraquelli M., Fargion S., et al. Comparable frequency of hepatocellular carcinoma in cirrhosis of different etiology. Eur J Gastroenterol Hepatol 6 (1994) 1129-1134
17. Imai Y., Kawata S., Tamura S., et al. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med 129 (1998) 94-99
18. De Mitri M.S., Poussin K., Baccarini P., et al. HCV-associated liver cancer without cirrhosis. Lancet 345 (1995) 413-415
19. Theise N.D. Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. Gastroenterology 111 (1996) 526-528
20. Borzio M., Bruno S., Roncalli M., et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis; a prospective study. Gastroenterology 108 (1998) 812-816
21. Moriya K., Fujie H., Shintani Y., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4 (1998) 1065-1067
22. Ray R.B., Meyer K., and Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226 (1996) 176-182
23. Yasui K., Wakita T., Tsukiyama-Kohara K., and Funahashi S.I. The native form and maturation process of hepatitis C virus core protein. J Virol 72 (1998) 6048-6055
24. Ray R.B., Lagging L.M., Meyer K., and Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70 (1996) 4438-4443
25. Kim D.W., Suzuki R., Harada T., Saito I., and Miyamura T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 47 (1994) 211-220
26. Benvegnu L., Pontisso P., Cavalletto D., Noventa F., Chemello L., and Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 25 (1997) 211-215
27. Yamauchi M., Nakahara M., Maezawa Y., Satoh S., Nishikawa F., and Ohata M. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 88 (1993) 39-43
28. Kew M.C., Yu M.C., Kedda M., Coppin A., Sarkin A., and Hodkinson J. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African Blacks. Gastroenterology 112 (1997) 184-187
29. Salata H., Cortes J.M., de Salamanca R.E., et al. Porphyria cutanea tarda and hepatocellular carcinoma-Frequency of occurence and related factors. J Hepatol 1 (1985) 477-487
30. Turlin B., Juguet F., Moirand R., et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 22 (1995) 446-450
31. Kao J., Chen P., Lai M., et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 112 (1997) 1265-1270
32. Tagger A., Donato F., Ribero M.L., et al. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Hepatology 26 (1997) 1653-1657
33. Lightfoot K., Skelton M., Kew M.C., et al. Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans?. Hepatology 26 (1990) 740-742
34. Mor E., Kaspa R., Sheiner P., and Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129 (1998) 643-653
35. Miller W.J., Baron R.L., Dodd G.D., and Federle M.P. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
36. Chang M., Chen C., Lai M., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 (1997) 1855-1859
37. Alter M.J., and Mast E.E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 23 (1994) 437-451
38. Nishiguchi S., Kuroki T., Nakatani S., et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346 (1995) 1051-1055
39. Mazzella G., Accogli E., Sottili S., et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 24 (1996) 141-147
40. Fattovich G., Giustina G., Degos F., et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol 27 (1997) 201-205
41. Kasahara A., Hayashi N., Mochizuki K., et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 27 (1998) 1394-1402
42. Miyajima I., Sata M., Kumashiro R., et al. The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment. Oncol Rep 5 (1998) 201-204
43. Ikeda K., Saitoh S., Arase Y., et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic type C hepatitis: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29 (1999) 1124-1130
44. International Interferon Hepatocellular Carcinoma Study Group, Brunetto M., Oliveri F., Koehler M., Zahm F., and Bonino F. Effect of interferon on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 351 (1998) 1535-1539